The sharp sequential improvement in gross margin from 14.2% in Q4 2025 to 33.9% in Q2 2026 suggests that lower-cost inventory and price resets are flowing through, but the trailing twelve-month net margin of -9.9% reflects the lingering impact of prior-period losses and inventory write-downs. Operating margin of 26.0% in Q2 2026 versus -20.7% in Q4 2024 highlights the extreme operating leverage in this business, yet the sustainability of these margins depends on lithium prices holding above cash costs. Investors should monitor whether the Q2 2026 margin expansion is durable or a one-time repricing benefit, especially given that revenue growth remains negative at -4.4% year-over-year.

The transition from a ROIC of -1.6% in Q4 2024 to +3.1% in Q2 2026 is driven primarily by margin recovery rather than asset efficiency, as asset turnover remains low at 0.11x. The company's heavy fixed-asset base, with PP&E at 53% of total assets, means that returns on capital are highly sensitive to cyclical pricing; the current ROIC of 3.1% is still far below the levels seen in prior lithium upcycles. This suggests that while the worst may be over, the company is not yet generating returns that justify its capital intensity, and investors should watch whether ROIC can sustain above 5% as the cycle matures.

DSO fell from 78 days in Q1 2025 to 36 days in Q2 2026, while DIO dropped from 154 to 108 days, indicating that the company is managing inventory levels more tightly in response to the price downturn. DPO also declined from 91 to 63 days, which may reflect reduced purchasing activity or improved payment terms, but the net effect is a significant release of cash from working capital. This efficiency gain is a positive sign, but it may be partly a function of lower sales volumes rather than structural improvement; if volumes recover, the cycle could lengthen again.

The reduction in total debt to $2.0 billion, combined with a rebound in operating income, has transformed interest coverage from negative in late 2025 to a robust 15.0x in Q2 2026. This deleveraging appears deliberate, as the company has cut capex dramatically and generated strong free cash flow, but the low D/E of 0.19 may also reflect a recent equity raise or asset sales that warrant verification. The improved coverage provides a cushion against further lithium price weakness, but investors should note that D/EBITDA of 2.61x is still elevated relative to the cyclical trough, and any sustained margin compression could quickly erode this progress.

The quick ratio of 1.35 indicates that even excluding inventory, the company can cover its current liabilities, which is reassuring given the inventory write-down risk in a falling price environment. The build-up in cash and the reduction in debt suggest that management is prioritizing balance sheet strength over growth, which is prudent given the cyclicality of lithium. However, the current ratio has declined from a peak of 2.84 in Q1 2024, and the reliance on inventory (DIO of 108 days) means that a further price drop could impair liquidity through additional write-downs.